RePORT International Resources

A free educational tool for healthcare providers treating pediatric TB. Updated in May 2025, it includes a five-part video series (64 minutes) by Dr. Ann M. Loeffler and downloadable clinical tools and handouts.

This 3-session webinar series highlight lectures from The Union-North American Region (NAR) 2025 Annual TB Conference. This webinar includes 1. The Riddle of TB Drug Resistance, 2. What is Hot in Treatment Differentiation and Individualization and 3. Reframing Directly Observed Treatment.

The UCSF Curry International TB Center offers free training opportunities for healthcare and public health professionals involved in TB prevention and care. Core trainings cover key topics such as case management, contact investigation, LTBI, clinical care, and program management, and are available in both hybrid and in-person formats. All trainings are free of charge, but registration and application are required. For further questions, please contact: CurryTBCenter@ucsf.edu.

Offers funding and support across all academic disciplines and industrial areas from the medical and biological sciences to astronomy, physics, chemistry and engineering, social sciences, economics, environmental sciences, and the arts and humanities.

To address the need for trustworthy and scientifically based information focused on providing a basic understanding of science, HANC responded by creating an ad-hoc work group with international membership to develop videos on several important topics. On this page you will find videos and links to additional resources that aim to make understanding science and clinical research easier. Videos include: Why is Science Essential?, Why is Research Important in Science?, Who are Clinical Research Stakeholders?, The Scientific Method, and Regulations and Clinical Research Studies.

This webinar covered Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in persons with TB and how to medically manage these patients.

Unitaid supports in making new health products available and affordable for people in low- and middle-income countries. It identifies innovative treatments, tests and tools, help tackle the market barriers that are holding them back, and get them to the people who need them most – fast. It provides health partners with financial grants to accelerate innovation in global health.

RePORT Indonesia, in partnership with the TB Alliance and the Respiratory Programmatic and Research Institute, have developed Upskill TB, a free online learning platform designed to enhance knowledge and skills in the treatment and management of drug-resistant tuberculosis. The current version has expert-led courses on the innovative BPaL/M regimen.

The RePORT International Long TB project will collect data in a variety of ways. 1. A central REDCap build hosted at Frontier Science. All sites must register for accounts to access this central REDCap build to log participant data. 2. The File Exchange Utility (FEU) hosted at Frontier Science. All sites must register for accounts to access this utility to upload de-identified DIACOM scan files. 3. The Data Submission System (DSS) hosted at Frontier Science. All sites must register for accounts to access this utility to upload information about specimen storage and availability. This guide includes instructions for registering for accounts and for accessing and using these tools.

The VALIDATE Network aims to accelerate vaccine research and development for three groups of complex neglected intracellular pathogens that cause significant mortality and morbidity throughout the world, particularly in low-and-middle-income countries (LMICs): Mycobacteria (causing tuberculosis, leprosy and other diseases), Leishmania (causing leishmaniasis) and Burkholderia pseudomallei (causing melioidosis). A second, important aim of the VALIDATE Network is to facilitate career progression for its members, particularly Early Career Researchers (ECRs), and (recognising career progression inequity) researchers from LMICs and researchers identifying as female and/or non-binary. CALL FOR ROUND 6 AWARDS IS EXPECTED IN DECEMBER 2025

This monthly webinar series covers the research and publishing process. Featuring Sage and external speakers from various disciplines, this series addresses the stumbling blocks every researcher encounters at the beginning of their careers and provides practical and in-depth guidance to help get published. For more information and to register for each webinar, click the links below. All webinars occur at 8 am PT/11 am ET/5 pm CET. You can also watch recordings of the previous webinars in the series by scrolling down to our webinar library, where you can find links to all the recordings and topics available at your fingertips anytime, anywhere.

Deadline: Rolling Weiss Asset Management Foundation invites proposals from organizations and researchers that engage in highly cost-effective work to alleviate human suffering in low- and lower-middle-income countries. Most grants will range from approximately $50,000 to $1.5 million. There is no lower bound, and in exceptional circumstances, grants may exceed $1.5 million.

This scheme provides funding for early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they will deliver shifts in understanding related to human life, health and wellbeing. By the end of the award, they will be ready to lead their own independent research programme. The applications are opened 3 times a year

Wellcome - Grants and Fundings - Searchable Database

This learning platform is custom-built to host high-quality courses developed by the WHO Academy, along with a wide range of quality-approved content from trusted providers. It offers personalized learning pathways, interactive tools, and collaborative features.

This website provides access to the latest WHO recommendations on all aspects of tuberculosis prevention and care. The user can search, filter and cross-tabulate the recommendations through built-in functions. For each individual recommendation one can also access key background information, such as the evidence summaries and the Guideline Development Group decisions underpinning it.

This call to action accompanies the consensus statement on the optimal and early inclusion of pregnant and lactating women in tuberculosis research and specifies the actions that need to be taken to ensure full implementation of the agreed approaches in the statement. The target audience includes product developers and industry, study sponsors, funding agencies, researchers and research networks, regulatory authorities, institutional review boards (IRBs) and ethics committees, national TB and maternal and child health programmes, civil society organizations and affected communities, and health care providers.

This WHO training kit helps manufacturers and regulators, especially in low- and middle-income countries, learn how to produce safe, effective, and high-quality vaccines, medicines, and diagnostic tests. It compiles expert-reviewed Q&As from the “Week of Quality” training on quality standards, regulatory compliance, and product development, serving as a reference for strengthening local production.